Skip to content

Market explorer

Screen the results we have checked

Search and filter our published results. This is selected coverage, not a screen of every listed stock.

Read the basis before comparing. Revenue is the company's reported revenue line, not a standardised comparable measure. Excise, acquisitions, exceptional items and different reporting periods can change growth. Missing revenue or growth is not zero. Each result below keeps its filing basis and caveats. No live prices, valuation filters or recommendations.

1 matching results out of 156 published entries. 69 have revenue growth available.

Senores Pharmaceuticals

+24.94% revenue YoY

Q2 FY2027 · Period ended 30 Sep 2026

Basis: Consolidated, unaudited

Reported revenue (₹ crore, except EPS in ₹/share): 192.33

Read summary and comparison caveats

Senores Pharmaceuticals' September-quarter revenue rose 24.94% year on year to ₹192.33 crore. Profit attributable to equity holders was ₹39.49 crore, up 21.96% year on year. The defined operating EBITDA margin was 29.98%, compared with 27.08% a year earlier.

  • The group acquired 75% of Apnar Pharma on 16 Jan 2026 and consolidated it from acquisition; year-on-year comparisons therefore include a changed group perimeter.
  • Source: consolidated statement, PDF page 5. Values are ₹ crore, except reported basic EPS in ₹ per share; EPS is not annualised.
  • Year ago is the quarter ended 30 Sep 2025; previous quarter is 30 Jun 2026. Changes use reported statement values; EPS changes use reported rounded EPS.
  • EBITDA is computed as profit before tax plus finance costs plus depreciation and amortisation minus other income. Margin is this measure divided by revenue from operations.
  • Equity-holder profit of ₹39.49 crore is higher than total consolidated PAT of ₹36.60 crore because non-controlling interests recorded a ₹2.89 crore loss. The same attribution basis is used for comparisons.
  • Detected through RSS and separately checked against the original statement. Raw notice timestamp has no supplied timezone suffix; this is selected checked coverage.

Checked 29 Oct 2026

Open original filing
Read the complete published results desk